Walden University NURS 6630Case 2 week 9 discussionWalden University NURS 6630Case 2 week 9 discussionWalden University NURS 6630Case 2 week 9 discussionWalden University NURS 6630Case 2 week 9 discus

**** ******** * **** ****** *************** ****** ***** ******** has **** **** Mother **** ******** **** **** study ** ***** * 26-year-old ******** ***** *** *** two ***** ******** *** ********** ******** *** recently diagnosed **** **** During *** ************ ************ ** was noted **** **** patient also had **** ******** ** ADD ** *** ******* that *** ***** ** ********* from *** same ********* ***** *** been *********** *** *** **** *** ******** about *** heritability ** ADD *** been ******* for ******* This ******** ********* **** genes **** a ***** role ** *** ******** ** ********* ******* hyperactivity ******** ****** *** its *********** with ***** ************ heritability ** *** is *********** ***** ******* ***** ****** *** first *********** **** **** patient ** is discovered **** she is **** ********* from *** At *** ********* ** this scenario *** question is presented ** to whether or *** ** is a good **** to ********* * stimulant to a patient with GAD *** ******* of **** ******** ** **** ********** will ******** anxiety and ****** *** ********* ***** ******** the ***** ***** ** **** to *** ***** of *** *** *** **** ** seems ** ***** *** ******** that ***** *** ************ ** ******** *** *** **** depression *** ** *** ******** ** *** ** **** ** ******* ************* ** ******* ** the adult ********** ******* from ADHD A very ***** ********** ** those ****** have ******** ** ******* and ********** *** third ** ****** **** ADHD **** * depressive ******** ****** ********** ** ************* ************* one ** eight **** a generalized anxiety *************** ***** *** ******** ** my **** is which **** ***** *** chicken ** the egg *** *** ***** * ******* was ********* was *** *** ** *** *** ** ******* *** symptoms ** ******* **** treating the *** ***** alleviate the anxiety *********** ********** *** independent conditions **** ***** concurrently in * ******* ** ******** ********** and ******* ******** **** ***** ** ******** with ADHD ********** *** a direct ****** ** the **** *** continue ** ***** **** ** untreated ******** ** ADHD” (Feifel 2007)If *** ******* **** comorbid **** it can be ******* after ** is ********** *** *** ******* ******** to the ********* ** *** *** * ****** **** *********** the *********** *** * **** choice to ***** treatmentThree ********** Will *** **** *** describe **** *** ******* ** ** the *** **** ******** *** **** ***** *** **** *** ***** **** to ***** ** resolving? * would ** **** to **** define *** goals ** ********* To evaluate the effectiveness ** therapy ********* *** *********** priorities *** ********** *** *********** **** ** ** ********** **** will **** ********** ******** **** *** ** the ***** ** ********* *** instance controlling ** *********** the *********** *** ***** in ************ ** her children ** ***** ****** to organize *** life If *** *** ********** ******** or ********** projects *** ** constantly ******* ****** *** ***** ****** ******* ** ****** so infrequent that **** are insignificant that ** ******** *** **** **** * ******** *********** ** *** progress ******* **** things *** getting ****** will **** with the ******* and ********** ** ***** What ******* ********** or issues are *** *** ***** ******* *** ** have **** in *** ***** ******* ************ ** ******* substances *** **** to treat ********* ******* ********* ** is ********* ** **** ***** the *********** physical ********* ******** ********** heart ******* cardiac *********** ******** liver or ****** ********** mania tics ********* ***** ***** failure *** even ******** may ** ***************** *** *********** *** stimulants ** *** very ***** *** patient’s ****** ** monitored for ***** *********** ** you **** * family ******* of *** of *** ***** conditions? **** ******* ******** have ******* risk ******* **** if *** ******* ** *** *** ***** has been ********* or treated for ***** ******** ** ** prudent ** know *** ***** **** **** *** ****** ** ***** ****** ********* ** ***** ************** ****** ** ** ***** ********* I ***** ** **** to ********* her parents ** ******** ******** of ADD **** ******* ** childhood ******* *** ** **** to **** * medical ******* **** the patient *** *** been ***** existed **** ******* *** ******* however **** ******** *** ** *** **** ********** information *** *** *********** ******* ** would **** ** nice to speak to ******* *** those *** interacts **** professionally *** ********** to *** ** **** ** the ******** ** symptoms ** *** ****** *** patient *** have ********** ** ****** ****** accustomed ** ** normal ***** perspectives *** aid ** *** ******* diagnosis ** **** ** ************ ** successful ********* ** **** ****** interviewing her ******** ***** also be ******* ** ********* a *********** **** ** what difficulties she struggles **** *** **** ********* ****** be *** ************* ************ ********** ***** ********* ******* Disorder **** ********* Anxiety: **** ******* ******** ** withat least fiveof *** ****** ******** related ** inattention *** ************* *************** ****** the *** ** ** and **** ********* ****** **** *** ****** These ******** **** interfered **** her ******* to ******** and ******** ************* ** ** ****** heritableand *** daughter has been diagnosed(American Psychiatric ************ **** ***** ********* **** far **** *** ****** *********** ******* ********* *** ******** ** ********* anxiety *** ***** about * variety ** topics ****** or ********** *** ***** *** ****** **** six ****** it ** *********** ** ******* *** shifts from *** topic ** ******* *** ** ********* ** ****** ********** about ******** ***** the future ***** *** ************ ******* ***** ******* * ****** *** ***** getting *** ********* ***** finding * new partner”Her ******* ** accompaniedwith edginess and ************ **** ***** ** *********** *** ********** ****** it *** ** *** ********* *** *** impaired ************* ** *** the ******* ** ****** *** **** **** blank **** ***** things and misses ************ *** ******* **** *** ******** ************** ********** sleeping (due to ******* falling ****** ** ******* asleep ************ ** ***** ** ************ ****** She also ******** “having ********** *********** These symptoms are **** ** the *** * ********** ******** *** ******** **** ******** and ****** *** ************ ********* to ***** *** ****** things ************* and feelings ** being *********** *** ** ******** ** ********** **** ********* mimic ******** **** ******** and *********** *** ******** and severity of ******** *********** ************ for *********** ******** **** ** be ********* ********* ** ****** **** *** ********* is ******** *** ********* options can ** ******** ****************** *********** ************* ****** *** *** *********** **** ******* Long-acting ********* preparations *** recommended for *** ********* ** ******** ** **** ****** ** ****** ***************** and ************** ******** improvement ** ****************** ******* *************** and *********** ********* ********** *** *** **** effective medications *** *** treatment ** **** with ************** ***** ** *** 70%–80% ***** ************** is ************* connected **** *** ************** activity ******* ************ ******** ** associated **** the lower ******** ********** **** ********** **** *** dopamine transporter ******* ******* ** *** **** membrane *** ***** ******** ******** presynaptically **** ********** synaptic ******** It *** **** ************ **** striatal ******** transporter ************ ** ***** ******** **** ADHD ** markedly ******* ** *************** **** at a *** **** *************** ** *** ***** **** ******** *********** ************** efflux *** **** *** seem ** ****** ******** ** *** ******* accumbensStimulants **** ***** * **** behavioral ******** in ******** ********** controlled ****** ********* ***** the 1960s **** improvement noted *** 65%–75% ** ******** ** *** *** ****** ********** effectively alleviate *** symptoms ** **** ********* **** ********* **** distractibility impulsive behavior ************* *** ************ ********** **** ******* ********* cognition reaction **** response ********** *** short-term ****** *************** ** ******** doses ******** spatial ******* memory ************ *** other ********** cortex ********* functions ** healthy *********** and ******** **** **** ********* *********** *** **** ********** **** ***** ****** on a ******* simulator ** ***** *** ****** **** ADHD Barkley *** colleagues demonstrated **** *************** ***** **** * beneficial ****** ** **** ******* ** driving *** example **** ******** *********** ****** driving ***** ******* *** ** turn ******* *** ***** ********* *************** ** ** ********* administration of ********** ******** ***** of *** stimulant methylphenidate blocks the ************ for **** NE *** ** *************** *** *** *** ********** with *********** ***** much more potent **** thel-isomer on **** *** and *** ******* Oral administration ** ********** ******** ***** ** *** ********* amphetamine **** methylphenidate **** ****** *** ************ both for NE and ** (NET and DAT) *** ** a different ****** ****** methylphenidate and *************** *********** is * *********** inhibitor *** *************** *** *** *** ********* ***** ** ******* as ****** *** ******* ** wrong **** either ***** * **** **** ****** ****** researching ********** * *** *** ** ** the ***** ***** ******* *** kinds ** **** ****** ** ******** to **** * ******* ************* to ** ******** *** **** out * *** wrong wrong wrong! *** our ******** **** *** **** ********** ***** **** ***** *** ***** ** *********** **** for the ********* of ADHD *** ******** *********** ** *** actions of *********** ****** *************** *** be ********** ************** ********* ********* University ********* *** textand **** **** *** patient ******** (the ********** I *** **** for AADD and **** ** son was prescribed ** * **** ***** *** *** ***** *** **** Ritalin **** ********** * am going ** *** **** *** ***** *** ***** ** ****** *** ** **** ** ****** ** ***** or **** dexamphetamine **** **** that psychiatrists ******* ** ** *** AADD) I am sticking **** *** ********** * **** **** ****** *** ****** ******* **** might **** **** blood ******** or **** glaucoma This ******* **** *** ** ****** ***** isn’t anything ********* ** *** history **** ***** *** * **** **** *** ************** or ******** ******** ****** *** ******** ** *** of *** ******** **** ***** **** ** stop **** ****** ** my tracts! * **** experienced *** very ******** ******* ** *** *** diagnosed **** **** ******* * **** ******* ***** **** ****** and *** * suspicion and **** *** ** a ***** ************ who **** *** * ***** *********** *** *** ** *** Several ******* after that ***** ** ***** ** *** **** * ******** having ** not because I ******* ***** diagnosis *** ******* I thought * *** dealing with it just fine *** *** * ******* to go for ** because I *** **** *** tired ** what ****** like ********* ***** ****** ********** ****** Dexadrine **** ********* *** **** ***** I ******* ** was * ***** of baloney and quit ****** **** year *** a **** * ********* ***** ********** I had never had them before * ********** function I **** ** * *** ****** I was ******* *** **** ***** ***** ********* ** ***** ******* * asked ** **** ** ******** **** ******* * was ****** ******** ** ****** *** ********** ******* *** ***** attacks stopped * ***** **** ***** ***** ** ****** ************* ** ********** ******** take **** class; *** went ** ********** *** was ********** as *** I * ******* **** Xanax ** ****** not **** Buspar Those treatments failed ** GAD *** **** a ******* ** ********* AADD! * *** ** ********** ** dopamine and ************** ****** **** **** just **** * ******* like ********** for adults yet * can testify **** *** ******** from ****** studies **** ** right ** track! * ** **** * ******* *** *** behind ** all taking **** class I may *** **** a ***** ** back ** ** but I **** ***** **** *** ********* every **** ******* I **** been ***** *** **** ********** Points *** prescriber in **** ******** ******* **** ******** The ****** ** for **** * 8 *** ** *** *** ** believe **** ****** was ** *** ***** ***** ** ******** as ********* ** *** ********** the *** wanted ** ** be *** ****** *** adjusted **** *** ******** *** ******* *** ********** ******* *** focus *** about * **** *** treating AADD! **** ******* ******** ***** ** *** patient **** ** vacation *** ********** ****** how *** ******* would **** ******** *** daily ******* ** cope *** ******** *** ***** did ******* ********* **** *** *** ******* **** again *** dosage adjustments ****** ** *** *** the ******* *** ******** ** another **** * ********* based treatment **** *************** ********** Methylphenidate ** Ritalin Ritalin *** the ** ** *** **** ****** ******** in town *** ********* **** **** **** ** attention *************** is * **** ****** **** ***** *** *********** in *** **** ****** ***** ** stimulants **** **** * ********** in how *** **** ** ******** The ***** **** ** ** ******* **** ** *** medication quickly ** *** the ****** started *** ** the **** **** ***** a **** slow ***** ** a longer ****** ********* of ********** **** keeps * ****** ***** ** ****** **** *** ******* dose *************** ******* * ******* that CNS ********** are ***** *** ** to for *** ********* ** ********* deficit disorders ** ****** * also ******* *** the **** ****** formulations work ***** ** important when ********** the ************* of treatment ***** ** *** patient’s ********* *** ******** *** **** *** to **** *** to ****** between ************ and *************** ** ** ***** **** one *** ******** *** ******** * ******* that ******** **** ***** *** CNS ********** *** *** ** * ****** choice *** *** ********** patient and ***** ***** *** be * *** to ********* **** ***** of **** * ******* *** to *** discouraged ** ****** *** ********* *** ******** ** things *** **** *** **** ** *** endSummary *** most ********* ***** of ***** *** *** treatment ** ADD ** adults are *** stimulants **** vary ******* ** *** way they are ******** *** **** on patient response Although *** ********* *** not achieve *** ******* effect that ****** **** *** **** out * ****** a ***** ** another ********* *** opportunity **** **** ******** different ******* and **** ********* ******* ** ******* The **** ***** ** ** ***** **** ** ***** *** ******* dosage and medication ** *********************** Psychiatric Association **** ********** and *********** manual ** ****** ********* ** *** (Ed) ********** DC ********* **** ******************************************************************************************************* S * ***** ******* * ***** **** *** ******** ** attention ******* hyperactivity ******** ********* ********** ********* **** ***************************************************** * ***** ********* **** in ****** the ********* ********** *********** ***** 60-62 Retrieved from https://wwwncbinlmnihgov/pmc/articles/PMC2861517/Kolar D ****** A Golfinopoulos * ***** * Syer * ***** Hechtman * ****** ********* ** ****** **** ******************************* ******** **************** ******* *** ********* **** ******* Retrieved **** ****************************************************** S * (2008) ********* ****************** ****** ********* from ******************************************************************************

Click here to download attached files: docx-(3).docx